European Medicines Agency officially approves the use of the Pfizer–BioNTech COVID-19 vaccine for children between the ages of 5 and 11 years
The European Medicines Agency officially approves the use of the Pfizer–BioNTech COVID-19 vaccine for children between the ages of 5 and 11 years, becoming the first vaccine to be approved for these age groups in Europe.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan to read this report and the complete Premium retrospective archive.
HealthEuropean Medicines Agency officially approves the use of the Pfizer–BioNTech COVID-19 vaccine for children between the ages of 5 and 11 years
View Premium plansBrowse free archive reportsThe European Medicines Agency officially approves the use of the Pfizer–BioNTech COVID-19 vaccine for children between the ages of 5 and 11 years, becoming the first vaccine to be approved for these age groups in Europe.